345 related articles for article (PubMed ID: 23945440)
1. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor α promotes the synthesis of monounsaturated fatty acids in goat mammary epithelial cells via the control of stearoyl-coenzyme A desaturase 1 in an SREBP-1-dependent manner.
Yao DW; Luo J; He QY; Xu HF; Li J; Shi HB; Wang H; Chen Z; Loor JJ
J Dairy Sci; 2016 Aug; 99(8):6391-6402. PubMed ID: 27209141
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Chu K; Miyazaki M; Man WC; Ntambi JM
Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule.
Zhang Y; Zhang X; Chen L; Wu J; Su D; Lu WJ; Hwang MT; Yang G; Li S; Wei M; Davis L; Breyer MD; Guan Y
Am J Physiol Renal Physiol; 2006 May; 290(5):F1065-73. PubMed ID: 16368743
[TBL] [Abstract][Full Text] [Related]
6. Activation of LXRα induces lipogenesis in HaCaT cells.
Hong I; Rho HS; Kim DH; Lee MO
Arch Pharm Res; 2010 Sep; 33(9):1443-9. PubMed ID: 20945144
[TBL] [Abstract][Full Text] [Related]
7. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
[TBL] [Abstract][Full Text] [Related]
8. Effect of synthetic ligands of PPAR α, β/δ, γ, RAR, RXR and LXR on the fatty acid composition of phospholipids in mice.
Weiss K; Mihály J; Liebisch G; Marosvölgyi T; Schmitz G; Decsi T; Rühl R
Lipids; 2011 Nov; 46(11):1013-20. PubMed ID: 21792736
[TBL] [Abstract][Full Text] [Related]
9. Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element.
Caputo M; De Rosa MC; Rescigno T; Zirpoli H; Vassallo A; De Tommasi N; Torino G; Tecce MF
Cell Biochem Funct; 2014 Dec; 32(8):637-46. PubMed ID: 25264165
[TBL] [Abstract][Full Text] [Related]
10. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
Qin Y; Dalen KT; Gustafsson JA; Nebb HI
Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
[TBL] [Abstract][Full Text] [Related]
12. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
14. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
[TBL] [Abstract][Full Text] [Related]
17. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
19. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
20. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]